Original article by Jill Margo
The Australian Financial Review – Page: 3 : 7-Apr-21
The UK, Germany and Norway are among the countries that have reported cases of the blood-clotting syndrome that may be linked to AstraZeneca’s COVID-19 vaccine. The novel syndrome has been designated as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) by German scientists. The Thrombosis and Haemostasis Society of Australia and New Zealand has established a national committee on the new syndrome; Associate Professor Vivien Chen says it has some similarities to existing immune-driven clotting syndromes. A 44-year-old Melbourne man is Australia’s first suspected case of VIPIT.
THROMBOSIS AND HAEMOSTASIS SOCIETY OF AUSTRALIA AND NEW ZEALAND